Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

EGR1 upregulation following Venezuelan equine encephalitis virus infection is regulated by ERK and PERK pathways contributing to cell death.

Dahal B, Lin SC, Carey BD, Jacobs JL, Dinman JD, van Hoek ML, Adams AA, Kehn-Hall K.

Virology. 2019 Oct 31;539:121-128. doi: 10.1016/j.virol.2019.10.016. [Epub ahead of print]

PMID:
31733451
2.

Pulmonary Spindle Cell Carcinoma: A Rare Case Report.

Khan S, Dahal B, Siddiqui F, Norville KJ, Karki A.

Cureus. 2019 May 23;11(5):e4737. doi: 10.7759/cureus.4737.

3.

Three-dimensional porous carbonaceous network with in-situ entrapped metallic cobalt for supercapacitor application.

Tiwari AP, Chae SH, Ojha GP, Dahal B, Mukhiya T, Lee M, Chhetri K, Kim T, Kim HY.

J Colloid Interface Sci. 2019 Oct 1;553:622-630. doi: 10.1016/j.jcis.2019.06.070. Epub 2019 Jun 21.

PMID:
31247501
4.

Phloretin inhibits Zika virus infection by interfering with cellular glucose utilisation.

Lin SC, Chen MC, Liu S, Callahan VM, Bracci NR, Lehman CW, Dahal B, de la Fuente CL, Lin CC, Wang TT, Kehn-Hall K.

Int J Antimicrob Agents. 2019 Jul;54(1):80-84. doi: 10.1016/j.ijantimicag.2019.03.017. Epub 2019 Mar 28.

PMID:
30930299
5.

Weak localization and small anomalous Hall conductivity in ferromagnetic Weyl semimetal Co2TiGe.

Dulal RP, Dahal BR, Forbes A, Bhattarai N, Pegg IL, Philip J.

Sci Rep. 2019 Mar 4;9(1):3342. doi: 10.1038/s41598-019-39037-0.

6.

Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.

Lundberg L, Brahms A, Hooper I, Carey B, Lin SC, Dahal B, Narayanan A, Kehn-Hall K.

Antiviral Res. 2018 Sep;157:57-67. doi: 10.1016/j.antiviral.2018.07.005. Epub 2018 Jul 5.

PMID:
29981794
7.

Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication.

Bell TM, Espina V, Lundberg L, Pinkham C, Brahms A, Carey BD, Lin SC, Dahal B, Woodson C, de la Fuente C, Liotta LA, Bailey CL, Kehn-Hall K.

Viruses. 2018 Apr 13;10(4). pii: E191. doi: 10.3390/v10040191.

8.

Alterations in the host transcriptome in vitro following Rift Valley fever virus infection.

Pinkham C, Dahal B, de la Fuente CL, Bracci N, Beitzel B, Lindquist M, Garrison A, Schmaljohn C, Palacios G, Narayanan A, Campbell CE, Kehn-Hall K.

Sci Rep. 2017 Oct 30;7(1):14385. doi: 10.1038/s41598-017-14800-3.

9.

Involvement of DNA mismatch repair in the maintenance of heterochromatic DNA stability in Saccharomyces cerevisiae.

Dahal BK, Kadyrova LY, Delfino KR, Rogozin IB, Gujar V, Lobachev KS, Kadyrov FA.

PLoS Genet. 2017 Oct 25;13(10):e1007074. doi: 10.1371/journal.pgen.1007074. eCollection 2017 Oct.

10.

Magnetic nanoparticle-loaded alginate beads for local micro-actuation of in vitro tissue constructs.

Alshehri AM, Wilson OC Jr, Dahal B, Philip J, Luo X, Raub CB.

Colloids Surf B Biointerfaces. 2017 Nov 1;159:945-955. doi: 10.1016/j.colsurfb.2017.08.062. Epub 2017 Sep 4.

PMID:
28922717
11.

Interaction of proliferating cell nuclear antigen with PMS2 is required for MutLα activation and function in mismatch repair.

Genschel J, Kadyrova LY, Iyer RR, Dahal BK, Kadyrov FA, Modrich P.

Proc Natl Acad Sci U S A. 2017 May 9;114(19):4930-4935. doi: 10.1073/pnas.1702561114. Epub 2017 Apr 24.

12.

Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle.

Luitel H, Sydykov A, Schymura Y, Mamazhakypov A, Janssen W, Pradhan K, Wietelmann A, Kosanovic D, Dahal BK, Weissmann N, Seeger W, Grimminger F, Ghofrani HA, Schermuly RT.

Physiol Rep. 2017 Mar;5(6). pii: e13146. doi: 10.14814/phy2.13146.

13.

Diversity of free-Living nitrogen fixing Streptomyces in soils of the badlands of South Dakota.

Dahal B, NandaKafle G, Perkins L, Brözel VS.

Microbiol Res. 2017 Jan;195:31-39. doi: 10.1016/j.micres.2016.11.004. Epub 2016 Nov 18.

14.

The Major Replicative Histone Chaperone CAF-1 Suppresses the Activity of the DNA Mismatch Repair System in the Cytotoxic Response to a DNA-methylating Agent.

Kadyrova LY, Dahal BK, Kadyrov FA.

J Biol Chem. 2016 Dec 30;291(53):27298-27312. doi: 10.1074/jbc.M116.760561. Epub 2016 Nov 21.

15.

miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.

Shi L, Kojonazarov B, Elgheznawy A, Popp R, Dahal BK, Böhm M, Pullamsetti SS, Ghofrani HA, Gödecke A, Jungmann A, Katus HA, Müller OJ, Schermuly RT, Fisslthaler B, Seeger W, Fleming I.

Cardiovasc Res. 2016 Aug 1;111(3):184-93. doi: 10.1093/cvr/cvw065. Epub 2016 Mar 24.

PMID:
27013635
16.

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice.

Werner F, Kojonazarov B, Gaßner B, Abeßer M, Schuh K, Völker K, Baba HA, Dahal BK, Schermuly RT, Kuhn M.

Basic Res Cardiol. 2016 Mar;111(2):22. doi: 10.1007/s00395-016-0541-x. Epub 2016 Feb 24.

17.

Fever-Induced Brugada Syndrome.

Manohar S, Dahal BR, Gitler B.

J Investig Med High Impact Case Rep. 2015 Mar 23;3(1):2324709615577414. doi: 10.1177/2324709615577414. eCollection 2015 Jan-Mar.

18.

Evidence that the DNA mismatch repair system removes 1-nucleotide Okazaki fragment flaps.

Kadyrova LY, Dahal BK, Kadyrov FA.

J Biol Chem. 2015 Oct 2;290(40):24051-65. doi: 10.1074/jbc.M115.660357. Epub 2015 Jul 29.

19.

Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis.

Kosanovic D, Luitel H, Dahal BK, Cornitescu T, Janssen W, Danser AH, Garrelds IM, De Mey JG, Fazzi G, Schiffers P, Iglarz M, Fischli W, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Reiss I, Schermuly RT.

Eur Respir J. 2015 Oct;46(4):1084-94. doi: 10.1183/09031936.00018215. Epub 2015 Jun 25.

20.

Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.

Veith C, Zakrzewicz D, Dahal BK, Bálint Z, Murmann K, Wygrecka M, Seeger W, Schermuly RT, Weissmann N, Kwapiszewska G.

Thromb Haemost. 2014 Dec;112(6):1288-303. doi: 10.1160/TH13-12-1031. Epub 2014 Sep 18.

PMID:
25231004
21.

Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease.

Kosanovic D, Dahal BK, Peters DM, Seimetz M, Wygrecka M, Hoffmann K, Antel J, Reiss I, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Schermuly RT.

Pulm Circ. 2014 Mar;4(1):128-36. doi: 10.1086/675642.

22.

The peroxisome proliferator-activated receptor β/δ agonist GW0742 has direct protective effects on right heart hypertrophy.

Kojonazarov B, Luitel H, Sydykov A, Dahal BK, Paul-Clark MJ, Bonvini S, Reed A, Schermuly RT, Mitchell JA.

Pulm Circ. 2013 Dec;3(4):926-35. doi: 10.1086/674755. Erratum in: Pulm Circ. 2014 Jun;4(2):352.

23.

Rhodiola: an ordinary plant or a promising future therapy for pulmonary hypertension? a brief review.

Kosanovic D, Tian X, Pak O, Lai YJ, Hsieh YL, Seimetz M, Weissmann N, Schermuly RT, Dahal BK.

Pulm Circ. 2013 Sep;3(3):499-506. doi: 10.1086/674303. Epub 2013 Nov 11.

24.

Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.

Nkyimbeng T, Ruppert C, Shiomi T, Dahal B, Lang G, Seeger W, Okada Y, D'Armiento J, Günther A.

PLoS One. 2013 Sep 2;8(9):e73279. doi: 10.1371/journal.pone.0073279. eCollection 2013.

25.

ASSESSMENT OF DETECTION EFFICACY OF MYCOBACTERIUM TUBERCULOSIS IN SPUTUM SAMPLES BY REAL TIME PCR BASED METHOD.

Upadhyaya SK, Dixit SM, Shrestha S, Dangol SD, Pokhrel D, Banjara S, Shrestha KS, Hengoju S, Dahal BK.

J Sci Eng Technol. 2013 Jul;9(1):181-188.

26.

Adherence and non-adherence to treatments: focus on pharmacy practice in Nepal.

Bastakoti S, Khanal S, Dahal B, Pun NT.

J Clin Diagn Res. 2013 Apr;7(4):754-7. doi: 10.7860/JCDR/2013/4872.2905. Epub 2013 Apr 1.

27.

Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.

Wygrecka M, Dahal BK, Kosanovic D, Petersen F, Taborski B, von Gerlach S, Didiasova M, Zakrzewicz D, Preissner KT, Schermuly RT, Markart P.

Am J Pathol. 2013 Jun;182(6):2094-108. doi: 10.1016/j.ajpath.2013.02.013. Epub 2013 Apr 4.

PMID:
23562441
28.

Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?

Kosanovic D, Dahal BK, Wygrecka M, Reiss I, Günther A, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Schermuly RT, Banat GA.

Histol Histopathol. 2013 Jun;28(6):691-9. doi: 10.14670/HH-28.691. Epub 2013 Feb 25. Review.

PMID:
23436625
29.

Cofilin, a hypoxia-regulated protein in murine lungs identified by 2DE: role of the cytoskeletal protein cofilin in pulmonary hypertension.

Veith C, Schmitt S, Veit F, Dahal BK, Wilhelm J, Klepetko W, Marta G, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Fink L, Weissmann N, Kwapiszewska G.

Proteomics. 2013 Jan;13(1):75-88. doi: 10.1002/pmic.201200206.

PMID:
23161571
30.

Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.

Savai R, Pullamsetti SS, Kolbe J, Bieniek E, Voswinckel R, Fink L, Scheed A, Ritter C, Dahal BK, Vater A, Klussmann S, Ghofrani HA, Weissmann N, Klepetko W, Banat GA, Seeger W, Grimminger F, Schermuly RT.

Am J Respir Crit Care Med. 2012 Nov 1;186(9):897-908. doi: 10.1164/rccm.201202-0335OC. Epub 2012 Sep 6.

PMID:
22955318
31.

Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.

Kojonazarov B, Sydykov A, Pullamsetti SS, Luitel H, Dahal BK, Kosanovic D, Tian X, Majewski M, Baumann C, Evans S, Phillips P, Fairman D, Davie N, Wayman C, Kilty I, Weissmann N, Grimminger F, Seeger W, Ghofrani HA, Schermuly RT.

Int J Cardiol. 2013 Sep 10;167(6):2630-7. doi: 10.1016/j.ijcard.2012.06.129. Epub 2012 Jul 31.

PMID:
22854298
32.

Role of Src tyrosine kinases in experimental pulmonary hypertension.

Pullamsetti SS, Berghausen EM, Dabral S, Tretyn A, Butrous E, Savai R, Butrous G, Dahal BK, Brandes RP, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Rosenkranz S, Schermuly RT.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1354-65. doi: 10.1161/ATVBAHA.112.248500. Epub 2012 Apr 19.

PMID:
22516066
33.

PAR-2 inhibition reverses experimental pulmonary hypertension.

Kwapiszewska G, Markart P, Dahal BK, Kojonazarov B, Marsh LM, Schermuly RT, Taube C, Meinhardt A, Ghofrani HA, Steinhoff M, Seeger W, Preissner KT, Olschewski A, Weissmann N, Wygrecka M.

Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.

PMID:
22461388
34.

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension.

Pullamsetti SS, Doebele C, Fischer A, Savai R, Kojonazarov B, Dahal BK, Ghofrani HA, Weissmann N, Grimminger F, Bonauer A, Seeger W, Zeiher AM, Dimmeler S, Schermuly RT.

Am J Respir Crit Care Med. 2012 Feb 15;185(4):409-19. doi: 10.1164/rccm.201106-1093OC. Epub 2011 Dec 8.

PMID:
22161164
35.

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β.

Dahal BK, Heuchel R, Pullamsetti SS, Wilhelm J, Ghofrani HA, Weissmann N, Seeger W, Grimminger F, Schermuly RT.

Pulm Circ. 2011 Apr-Jun;1(2):259-68. doi: 10.4103/2045-8932.83448.

36.

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.

Kosanovic D, Kojonazarov B, Luitel H, Dahal BK, Sydykov A, Cornitescu T, Janssen W, Brandes RP, Davie N, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Schermuly RT.

Respir Res. 2011 Jun 23;12:87. doi: 10.1186/1465-9921-12-87.

37.

The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis.

Pullamsetti SS, Savai R, Dumitrascu R, Dahal BK, Wilhelm J, Konigshoff M, Zakrzewicz D, Ghofrani HA, Weissmann N, Eickelberg O, Guenther A, Leiper J, Seeger W, Grimminger F, Schermuly RT.

Sci Transl Med. 2011 Jun 15;3(87):87ra53. doi: 10.1126/scitranslmed.3001725.

38.

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.

Dahal BK, Kosanovic D, Kaulen C, Cornitescu T, Savai R, Hoffmann J, Reiss I, Ghofrani HA, Weissmann N, Kuebler WM, Seeger W, Grimminger F, Schermuly RT.

Respir Res. 2011 May 2;12:60. doi: 10.1186/1465-9921-12-60.

39.

Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases.

ten Freyhaus H, Dagnell M, Leuchs M, Vantler M, Berghausen EM, Caglayan E, Weissmann N, Dahal BK, Schermuly RT, Ostman A, Kappert K, Rosenkranz S.

Am J Respir Crit Care Med. 2011 Apr 15;183(8):1092-102. doi: 10.1164/rccm.200911-1663OC. Epub 2010 Dec 22.

PMID:
21177885
40.

Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction.

Egemnazarov B, Schermuly RT, Dahal BK, Elliott GT, Hoglen NC, Surber MW, Weissmann N, Grimminger F, Seeger W, Ghofrani HA.

Respir Res. 2010 Jun 21;11:81. doi: 10.1186/1465-9921-11-81.

41.

Inflammation, immunological reaction and role of infection in pulmonary hypertension.

Pullamsetti SS, Savai R, Janssen W, Dahal BK, Seeger W, Grimminger F, Ghofrani HA, Weissmann N, Schermuly RT.

Clin Microbiol Infect. 2011 Jan;17(1):7-14. doi: 10.1111/j.1469-0691.2010.03285.x. Review.

42.

Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension.

Dahal BK, Kosanovic D, Pamarthi PK, Sydykov A, Lai YJ, Kast R, Schirok H, Stasch JP, Ghofrani HA, Weissmann N, Grimminger F, Seeger W, Schermuly RT.

Eur Respir J. 2010 Oct;36(4):808-18. doi: 10.1183/09031936.00140309. Epub 2010 Jun 7.

43.

Role of epidermal growth factor inhibition in experimental pulmonary hypertension.

Dahal BK, Cornitescu T, Tretyn A, Pullamsetti SS, Kosanovic D, Dumitrascu R, Ghofrani HA, Weissmann N, Voswinckel R, Banat GA, Seeger W, Grimminger F, Schermuly RT.

Am J Respir Crit Care Med. 2010 Jan 15;181(2):158-67. doi: 10.1164/rccm.200811-1682OC. Epub 2009 Oct 22.

PMID:
19850946
44.

The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice.

Weissmann N, Hackemack S, Dahal BK, Pullamsetti SS, Savai R, Mittal M, Fuchs B, Medebach T, Dumitrascu R, Eickels Mv, Ghofrani HA, Seeger W, Grimminger F, Schermuly RT.

Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L658-65. doi: 10.1152/ajplung.00189.2009. Epub 2009 Jul 17.

45.

Arsenic contamination of soils and agricultural plants through irrigation water in Nepal.

Dahal BM, Fuerhacker M, Mentler A, Karki KB, Shrestha RR, Blum WE.

Environ Pollut. 2008 Sep;155(1):157-63. Epub 2008 Feb 20.

PMID:
18068879
46.

Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Markart P, Ruppert C, Wygrecka M, Colaris T, Dahal B, Walmrath D, Harbach H, Wilhelm J, Seeger W, Schmidt R, Guenther A.

Thorax. 2007 Jul;62(7):588-94. Epub 2007 Feb 7.

47.

Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation.

Raes G, Brys L, Dahal BK, Brandt J, Grooten J, Brombacher F, Vanham G, Noël W, Bogaert P, Boonefaes T, Kindt A, Van den Bergh R, Leenen PJ, De Baetselier P, Ghassabeh GH.

J Leukoc Biol. 2005 Mar;77(3):321-7. Epub 2004 Dec 9.

PMID:
15591125
48.

Public water sources in rural watersheds of Nepal's Middle Mountains: issues and constraints.

Merz J, Nakarmi G, Shrestha S, Dahal BM, Dongol BS, Schaffner M, Shakya S, Sharma S, Weingartner R.

Environ Manage. 2004 Jul;34(1):26-37. Epub 2004 May 13.

PMID:
15156351
49.

Seasonality in urinary and household salt iodine content among pregnant and lactating women of the plains of Nepal.

Schulze KJ, West KP Jr, Gautschi LA, Dreyfuss ML, LeClerq SC, Dahal BR, Wu LS, Khatry SK.

Eur J Clin Nutr. 2003 Aug;57(8):969-76.

PMID:
12879092
50.

Groundwater arsenic contamination, its health impact and mitigation program in Nepal.

Shrestha RR, Shrestha MP, Upadhyay NP, Pradhan R, Khadka R, Maskey A, Maharjan M, Tuladhar S, Dahal BM, Shrestha K.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003 Jan;38(1):185-200.

PMID:
12635826

Supplemental Content

Support Center